393 related articles for article (PubMed ID: 22968621)
21. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
Lin CQ; Singh J; Murata K; Itahana Y; Parrinello S; Liang SH; Gillett CE; Campisi J; Desprez PY
Cancer Res; 2000 Mar; 60(5):1332-40. PubMed ID: 10728695
[TBL] [Abstract][Full Text] [Related]
22. Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes.
Cao H; Urban JF; Anderson RA
Obesity (Silver Spring); 2008 Jun; 16(6):1208-18. PubMed ID: 18388887
[TBL] [Abstract][Full Text] [Related]
23. Hox genes in normal and neoplastic mouse mammary gland.
Friedmann Y; Daniel CA; Strickland P; Daniel CW
Cancer Res; 1994 Nov; 54(22):5981-5. PubMed ID: 7954431
[TBL] [Abstract][Full Text] [Related]
24. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
Iavnilovitch E; Groner B; Barash I
Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
[TBL] [Abstract][Full Text] [Related]
25. OZF gene expression in growing mouse and rabbit mammary gland and in rabbit mammary cells and Nb2 cells under prolactin action.
Puissant C; Lennaouar M; Le Chalony C; Goubin G; Houdebine LM
Biochem Mol Biol Int; 1996 Mar; 38(3):543-52. PubMed ID: 8829614
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages.
Leppänen T; Jalonen U; Korhonen R; Tuominen RK; Moilanen E
Eur J Pharmacol; 2010 Feb; 628(1-3):220-5. PubMed ID: 19925787
[TBL] [Abstract][Full Text] [Related]
27. Interplay between progesterone and prolactin in mammary development and implications for breast cancer.
Lee HJ; Ormandy CJ
Mol Cell Endocrinol; 2012 Jun; 357(1-2):101-7. PubMed ID: 21945475
[TBL] [Abstract][Full Text] [Related]
28. Signal transducer and activator of transcription 5a inhibited by pimozide may regulate survival of goat mammary gland epithelial cells by regulating parathyroid hormone-related protein.
Li H; Zheng H; Sun Y; Yu Q; Li L
Gene; 2014 Nov; 551(2):279-89. PubMed ID: 25194899
[TBL] [Abstract][Full Text] [Related]
29. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
30. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.
Jiang W; Zhu D; Wang C; Zhu Y
Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133
[TBL] [Abstract][Full Text] [Related]
31. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
Hou L; Xu B; Mohankumar KM; Goffin V; Perry JK; Lobie PE; Liu DX
Int J Oncol; 2012 Dec; 41(6):2285-95. PubMed ID: 23064471
[TBL] [Abstract][Full Text] [Related]
32. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
[TBL] [Abstract][Full Text] [Related]
33. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.
Al-Souhibani N; Al-Ahmadi W; Hesketh JE; Blackshear PJ; Khabar KS
Oncogene; 2010 Jul; 29(29):4205-15. PubMed ID: 20498646
[TBL] [Abstract][Full Text] [Related]
34. Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis.
Caffarel MM; Zaragoza R; Pensa S; Li J; Green AR; Watson CJ
Cell Death Differ; 2012 Mar; 19(3):511-22. PubMed ID: 21941370
[TBL] [Abstract][Full Text] [Related]
35. Identification of an AP1-ZFP36 Regulatory Network Associated with Breast Cancer Prognosis.
Canzoneri R; Naipauer J; Stedile M; Rodriguez Peña A; Lacunza E; Gandini NA; Curino AC; Facchinetti MM; Coso OA; Kordon E; Abba MC
J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):163-172. PubMed ID: 32248342
[TBL] [Abstract][Full Text] [Related]
36. Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation.
Vafaizadeh V; Klemmt P; Brendel C; Weber K; Doebele C; Britt K; Grez M; Fehse B; Desriviéres S; Groner B
Stem Cells; 2010 May; 28(5):928-38. PubMed ID: 20235097
[TBL] [Abstract][Full Text] [Related]
37. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
[TBL] [Abstract][Full Text] [Related]
38. PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development.
Grinman DY; Boras-Granic K; Takyar FM; Dann P; Hens JR; Marmol C; Lee J; Choi J; Chodosh LA; Sola MEG; Wysolmerski JJ
Breast Cancer Res; 2022 Apr; 24(1):30. PubMed ID: 35440032
[TBL] [Abstract][Full Text] [Related]
39. CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Fallahi M; Amelio AL; Cleveland JL; Rounbehler RJ
PLoS One; 2014; 9(12):e115517. PubMed ID: 25541715
[TBL] [Abstract][Full Text] [Related]
40. Reduced levels of ATF-2 predispose mice to mammary tumors.
Maekawa T; Shinagawa T; Sano Y; Sakuma T; Nomura S; Nagasaki K; Miki Y; Saito-Ohara F; Inazawa J; Kohno T; Yokota J; Ishii S
Mol Cell Biol; 2007 Mar; 27(5):1730-44. PubMed ID: 17189429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
